Comments
FDA staff question Novartis cystic fibrosis drug
01.09.2012. | WASHINGTON (Reuters) - U.S. drug reviewers questioned whether Novartis AG's experimental inhaled antibiotic powder truly helped cystic fibrosis patients breathe better, according to documents posted by the Food and Drug Administration on its website Friday....
